SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as its community fervently debates and anticipates a potential S&P 500 inclusion, which has sharply divided sentiment between expectations of a significant rally and fears of a decline, amidst broader market volatility.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as news circulates about the departure of a key FDA official, which the community believes removes a significant hurdle and could accelerate the approval path for their Duchenne Muscular Dystrophy (DMD) therapy, Deramiocel; this development, combined with upcoming Phase 3 data presentations, is intensifying short squeeze and buyout speculation.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is surging as a key FDA official's departure and reports of a less invasive trial design for its Huntington's gene therapy ignite community hopes for accelerated approval, triggering a significant short squeeze after a week of regulatory setbacks.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings (LITE) is trending amid its S&P 500 inclusion and a significant strategic investment from NVIDIA, solidifying its critical position in AI infrastructure expansion. The community is actively discussing whether its high valuation is justified by its role in supplying advanced optical components, particularly in light of industry perspectives on optical versus copper solutions for data center connectivity.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings Co. (VRT) is a major talking point among investors after its announcement to join the S&P 500 index on 3/23, leading to widespread discussion around anticipated 'inclusion play' gains and the implications of forced buying by index funds.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as CEO Doug Ingram's upcoming retirement, prompted by a personal family health challenge, sparks community discussion about potential M&A and a fresh leadership direction. This, coupled with optimism over a potentially evolving FDA regulatory landscape and anticipation for new siRNA pipeline data, fuels talks of the company's significant undervaluation and short-squeeze potential.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as its fortified balance sheet, recent defense contract wins, U.S. Army qualification, and a new CEO compensation plan tied to aggressive valuation milestones spark intense community debate, balancing optimism for its critical role in aerospace and defense against concerns over institutional exits, high short interest, and potential dilution.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

With upcoming clinical data readouts and potential international approvals for its personalized TIL therapy, Iovance Biotherapeutics is showing exceptional relative strength in a weak market, sparking community speculation of a significant short squeeze and potential buyout.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

NVIDIA's substantial investment and strategic partnership for optical interconnects has put Coherent at the forefront of the AI infrastructure conversation, with investors also discussing its recent S&P 500 inclusion as a key sector player.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is surging as escalating conflict with Iran significantly disrupts oil traffic through the vital Strait of Hormuz, driving the biggest weekly crude gains in decades. The community is actively debating whether this is a genuine physical supply squeeze or fear-driven, with many expecting oil to climb well past $100 as regional producers face storage limits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Despite the mixed Q4 performance, Sea CEO Forrest Li stated that 2025 was a great year for the company and that all its businesses scaled well, exceeding Sea’s growth expectations.</li><li>The company Shopee served around 400 million active buyers, Monee gained over 20 million unique first-time borrowers, and Garena connected on average with more than 100 million players daily throughout 2025.</li><li>Shopee’s gross merchandise value stood at $36.7 billion, growing 28.6% YoY, while core marketplace revenue surged by over 50% to $3.6 billion.</li></ul>Sea (SE) American Depository Receipts tumbled nearly 25% in Tuesday’s opening trade after the company reported mixed fourth-quarter (Q4) results, and the intensifying war in the Middle East pushed the broader markets down.The Singapore-based tech conglomerate reported earnings per share (EPS) of $0.63 on revenue of $6.85 billion, while Wall Street analysts expected an EPS of $0.81 on revenue of $6.43 billion, according to Fiscal.ai data.Sea is the holding company for the popular online games developer Garena, the digital payments and financial services provider Monee, and the e-commerce platform Shopee.<h2 class="st-heading-2">All Businesses Scaled Well, Says CEO</h2>Despite the mixed Q4 performance, Sea CEO Forrest Li stated that 2025 was a great year for the company and that all its businesses scaled well, exceeding Sea’s growth expectations.“In 2025, Shopee served around 400 million active buyers and 20 million sellers. Monee gained over 20 million unique first-time borrowers. And Garena connected on average with more than 100 million players daily throughout the year,” Li said.Sea stated in its announcement that Shopee registered a 30.5% year-on-year increase in Q4 gross orders. Gross merchandise value (GMV) stood at $36.7 billion, growing 28.6% YoY, while core marketplace revenue surged by over 50% to $3.6 billion.Sea’s financial services firm Monee registered an 80.4% YoY increase in its consumer as well as small and medium enterprises (SME) loans, which stood at $9.2 billion as of Dec. 31, 2025.Garena, Sea’s online games firm, registered a 23.8% YoY increase in bookings to $672.4 million in Q4, while quarterly active users edged up by 2.5% YoY to 633.3 million. Average bookings per user rose to $1.08, up from $0.88 in the same quarter a year ago.The company also provided an update on its $1 billion share repurchase program, stating that it had bought back shares worth $14.5 million in Q4.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/SE">Sea</a> trended in the ‘extremely bullish’ territory, with message volumes at ‘extremely high’ levels.One user flagged potential margin compression at Shopee, noting that the company still needs to demonstrate whether its long-term target of 2% to 3% GMV margins is achievable.<stembedurl>https://stocktwits.com/StockPlaza/message/646417862</stembedurl><a href="https://stocktwits.com/symbol/SE">SE ADR</a> is down 39% year-to-date and 38% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-warns-iran-too-late-for-talks/cZdehIWRIPe">Trump Warns It's 'Too Late' For Talks With Iran, Says Their Air Force, Navy, And Leadership Are Gone</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sea Ltd. is a Singapore-based global consumer internet company operating platforms such as Shopee, Garena, and Moneee

SE Stock Is Tumbling Today — Mixed Q4 Results Offer Little Hope Amid Raging Middle East Conflict

Singapore-based tech conglomerate Sea reported earnings per share of $0.63 on revenue of $6.85 billion, while Wall Street analysts expected an EPS of $0.81 on revenue of $6.43 billion.

Equity

<ul class="summary-bullets"><li>Nebius and CoreWeave are both neocloud or artificial intelligence infrastructure providers with GPU-first data centers.&nbsp;</li><li>Retail touted the dip in NBIS stock as a ‘buying opportunity,’ while also calling the company’s shares superior to CoreWeave’s because of its lower leverage.</li><li>CoreWeave has long-term debt of $14.67 billion as of Dec. 31, 2025, while Nebius has long-term debt of $4.1 billion as of the same date.</li></ul>Shares of Amsterdam-based Nebius Group N.V. (NBIS) slumped more than 13% on Friday amid a decline in rival CoreWeave Inc.'s (CRWV) shares. &nbsp;CoreWeave on Thursday <a href="https://stocktwits.com/news-articles/markets/equity/crwv-stock-slumps-on-coreweave-capex-projections-for-2026/cZTcmZKRITh">announced</a> that its capital expenditure plans for 2026 would be more than double of 2025, sending its shares down in Friday’s trade.Nebius and CoreWeave are both neocloud or artificial intelligence infrastructure providers with GPU-first data centers. Both companies are backed by Nvidia Corp. (NVDA) and operate on its chips.<h2 class="st-heading-2">What Is Retail Saying?</h2>On Stocktwits, retail sentiment around NBIS shares was in the ‘bullish’ territory amid ‘normal’ message volumes at the time of writing. The stock was among the most-trending on the platform.One bullish user said that CoreWeave’s dip just gave the market an ‘incredible buying opportunity.’<stembedurl>https://stocktwits.com/dailyalpha_2228/message/646097684</stembedurl>&nbsp;Another bullish user said that compute would be the future of the market and called it a ‘gift dip’.<stembedurl>https://stocktwits.com/Source206/message/646123644</stembedurl>&nbsp;A third user called Nebius the ‘winner’ when compared to CoreWeave.<stembedurl>https://stocktwits.com/omz24/message/646121668</stembedurl>&nbsp;Another bullish user gave Nebius the thumbs up, while giving CoreWeave a thumbs down, citing capital structure differences.<stembedurl>https://stocktwits.com/santacruztodd/message/646047422</stembedurl>&nbsp;<h2 class="st-heading-2">Capital Expenditure</h2>For 2026, CoreWeave has forecasted capital expenditure of $30 billion to $35 billion in 2026, compared to $14.9 billion spent in 2025. The company also reported long-term debt of $14.67 billion as of Dec. 31, 2025, compared to $5.4 billion as of Dec. 31, 2024.<figure class="image"><img src="https://news.stocktwits-cdn.com/Core_Weave_Long_Term_Debt_jpg_36378b7d22.webp" alt="CoreWeave_Long-Term_Debt.jpg" width="1600" height="1134"><figcaption>CoreWeave Debt From Dec. 2023 to Dec. 2025 | Source: Fiscal.ai</figcaption></figure>&nbsp;In comparison, Nebius reported long-term debt of $4.1 billion as of Dec. 31, 2025, a notable increase from zero debt the previous year, as it catches up to growing competition in the AI cloud market. Yet, its debt is significantly lower than that of CoreWeave’s.<figure class="image"><img src="https://news.stocktwits-cdn.com/Nebius_Group_Long_Term_Debt_jpg_898dd44895.webp" alt="Nebius_Group_Long-Term_Debt.jpg" width="1600" height="1134"><figcaption>Nebius had near-zero debt in 2023 and 2024 | Source: Fiscal.ai</figcaption></figure>&nbsp;However, Arkady Volozh, founder and CEO of Nebius, said in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://assets.nebius.com/assets/e59fb92e-9027-473a-8cac-04f9d2e9ea9a/Shareholder%20Letter%20Q4%202025.pdf?cache-buster=2026-02-12T11:43:13.446Z">letter to shareholders</a> on Feb. 12 that the company would “maintain a disciplined approach to raising capital” even as it considers a range of financing options for 2026, including corporate debt and asset-backed financing.<a href="https://stocktwits.com/symbol/NBIS">Shares of NBIS</a> have risen more than 178% in the past year, while s<a href="https://stocktwits.com/symbol/CRWV">hares of CRWV</a> have gained more than 93% in the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/coreweave-ceo-justifies-capex-spend-amid-stock-price-plummet-touts-high-demand/cZTcYsFRIT8">CoreWeave CEO Justifies Capex Spend Amid Stock Price Plummet, Touts High Demand: ‘Our Backlog Is Enormous’</a>

In this photo illustration, the Nebius Group logo is seen displayed on a smartphone screen. 

NBIS Stock Tanks Amid CoreWeave Decline — What Does Retail Think? 

CoreWeave on Thursday announced that its capital expenditure plans for 2026 would be more than double of 2025, sending its shares down in Friday’s trade. 

NBIS Stock Tanks Amid CoreWeave Decline — What Does Retail Think?

May 29th Options Now Available For iShares Trust - iShares MSCI EAFE ETF (EFA)

Investors in iShares Trust - iShares MSCI EAFE ETF (Symbol: EFA) saw new options become available today, for the May 29th expiration. One of the key inputs that goes into the price an option buyer is...

<ul class="summary-bullets"><li>TEV-'749 is designed to help improve patient adherence. &nbsp;</li><li>The treatment utilizes a copolymer technology proprietary to Medincell to provide a controlled steady, sustained release of olanzapine.</li><li>Earlier this week, the United States Court of Appeals for the Federal Circuit issued a ruling backing Teva in a patent dispute involving Corcept Therapeutics’ Korlym tablets.</li></ul> U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA) said on Friday that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension or TEV-'749 for the treatment of schizophrenia in adults.The application was based on data from a late-stage trial in which TEV-'749 administered as a once-monthly subcutaneous injection demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations and showed no evidence for the need for post-injection monitoring.Shares of TEVA traded marginally lower at the time of writing.<h2 class="st-heading-2">Drug Details</h2>Currently, long-acting olanzapine formulations require administration in a certified healthcare facility and require a 3-hour post-injection monitoring period. TEV-'749 is designed to help improve patient adherence. &nbsp;“Treatment adherence remains a major challenge and unmet need for people living with schizophrenia…,” &nbsp; said Eric Hughes, Chief Medical Officer at Teva. The treatment utilizes a copolymer technology proprietary to Medincell to provide a controlled steady, sustained release of olanzapine.Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts, and symptoms may include delusions, hallucinations, disorganized speech or behavior and impaired cognitive ability. As per the company, about 1% of the world’s population will develop schizophrenia in their lifetime.Teva is best known for its generics business. Earlier this week, the United States Court of Appeals for the Federal Circuit issued a <a href="https://stocktwits.com/news-articles/markets/equity/cort-stock-drops-after-appeals-court-sides-with-teva-in-korlym-patent-fight/cZRkeLuR4DQ">ruling backing</a> Teva in a patent dispute involving Corcept Therapeutics’ Korlym tablets.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around TEVA stayed within the ‘bearish’ territory while message volume stayed at ‘low’ levels.<a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> has more than doubled over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/praxis-precision-shares-rally-on-price-target-hikes/cZRNLcYR4xs">Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Teva Pharmaceutical Industries logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment 

The application was based on data from a late-stage trial in which TEV-'749 administered as a once-monthly subcutaneous injection demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations.

See Which Of The Latest 13F Filers Holds EFA

At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 12/31/2025 reporting period, and noticed that iShares Trust - iShares MSCI EAFE ETF (Symbol: EFA) was...

Noteworthy ETF Inflows: EFA, SPOT, SE, TEVA

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE ETF (Symbol: EFA) where we have detected an...

Ride-hailing, food delivery, and digital payment services provider, Grab Holdings (GRAB),&nbsp;reportedly stated that it is not currently pursuing a merger with Indonesia’s GoTo Group.Grab’s latest stance, according to a Bloomberg&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-06-09/grab-says-it-s-not-in-talks-to-buy-goto-at-this-time">report</a>, has paused speculation around a potential $7 billion deal that would have reshaped Southeast Asia’s tech landscape.The Singapore-based ride-hailing and delivery platform emphasized that no formal negotiations or binding agreements are underway, cooling previous reports of an imminent tie-up between the two regional giants.&nbsp;Earlier, discussions had reportedly stalled due to regulatory uncertainties, the report noted.The potential merger had raised red flags with Indonesia’s antitrust authorities, which voiced concerns about market concentration and urged the companies to maintain a competitive environment.&nbsp;The proposed combination of two dominant players in ride-hailing and food delivery has drawn political scrutiny, particularly over concerns about job losses and rising service costs in Indonesia’s already strained economy.Talks between Grab and GoTo have been ongoing for years, but they have consistently run into friction, mainly due to antitrust implications and concerns about national interest.Grab went public in 2020 through a special purpose acquisition company (SPAC) deal and currently holds a market valuation of about $21 billion.Grab, supported by Uber Technologies Inc. (UBER), and GoTo, which counts SoftBank Group Corp. among its backers, have each taken steps toward achieving profitability since going public.&nbsp;However, intense rivalry for market share has limited pricing power and pressured profit margins.GoTo exited markets such as Thailand and Vietnam as part of an aggressive effort to reduce expenses, yet it continues to hold significant influence in Indonesia, Southeast Asia’s largest economy.&nbsp;A takeover would have boosted Grab’s foothold in the nation, which is home to over 275 million people, said the report.For the first quarter, Grab recorded an improvement in its earnings, with a profit of $10 million, primarily due to a reduction in operating loss and higher net finance income.On Stocktwits, retail sentiment around Grab remained in ‘bullish’ territory.<figure class="image"><img style="aspect-ratio:644/81;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_082349_png_b0b0eddf3f.webp" alt="GRAB's Sentiment Meter and Message Volume as of 08:30 a.m. ET on June 9, 2025 | Source: Stocktwits" width="644" height="81"><figcaption>GRAB's Sentiment Meter and Message Volume as of 08:30 a.m. ET on June 9, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/GRAB">Grab</a> stock has gained over 9% in 2025 and 42% in the past 12 months.Also See:<a href="https://stocktwits.com/news-articles/markets/equity/ionq-stock-rises-after-1-billion-oxford-ionics-acquisition/chlEaMGRbyP"> IonQ Stock Rises After $1.1B Oxford Ionics Acquisition, But Retail Remains Wary</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Grab logo displayed on a phone screen is seen in this illustration photo taken in Krakow, Poland on July 8, 2021.

Grab Cools Off Merger Talks With GoTo, Says Report: Retail Keeps Faith

Grab has reportedly indicated a pause or potential halt in its merger talks with GoTo amid regulatory concerns and political backlash in Indonesia over concerns about competition and consumer impact.

Is WisdomTree International Equity ETF (DWM) a Strong ETF Right Now?

Sea Ltd (SE), the firm behind the Shopee e-commerce and Garena gaming platforms popular in Southeast Asia, swung to&nbsp;a profit last quarter, driven by the strong performance of its retail operations.U.S.-listed shares of the Singapore-headquartered company rose 8.2% to their highest level since November 2021 on Tuesday, lifting the sentiment among Stocktwits users.Sea reported per-share earnings of $0.65 in the first quarter, compared with a loss of $0.04 a year earlier.Revenue grew about 30% to $4.84 billion but it was below the analysts' estimate of $4.91 billion from FactSet."We have delivered another great quarter of strong growth with improving profitability across all three businesses," CEO Forrest Li said. Sea's third and smallest business segment is financial services.E-commerce revenue grew 28% to $3.5 billion, led by a 29% jump in marketplace sales. Revenue from the digital entertainment unit, which includes Garena, increased 8.2%.In March, the company projected that Shopee’s gross merchandise volume, or the total value of goods sold on the platform, would rise by approximately 20% in 2025, alongside gains in profitability.JPMorgan upgraded its rating to 'Overweight' after Sea's Q1 results.On Stocktwits, retail sentiment jumped to 'extremely bullish' from 'bullish' a day prior.A user said the rally showed "true momentum and buyer interest in the stock."<stembedurl>https://stocktwits.com/ronirona/message/614469774</stembedurl><a href="https://stocktwits.com/symbol/SE">Sea shares</a> are up 43.4% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Sea Limited is displayed on a smartphone screen. (Photo illustration by Cheng Xin/Getty Images)

Shopee Parent Sea Ltd Swings To Profit On Strong E-commerce Growth; Retail Investors Excited

Shares climbed 8% to their highest level since November 2021.

Ferrari's U.S.-listed stock closed over 3% higher on Thursday but slipped in extended trading after the company announced plans to raise prices on select models in response to new tariffs while maintaining its financial targets for the year.The Italian luxury carmaker assured that pricing would remain unchanged for orders placed before April 2, 2025, and for Ferrari 296, SF90, and Roma models regardless of import date.&nbsp;However, in coordination with dealers, prices for other models may rise by up to 10%.Despite this, Ferrari reaffirmed its 2025 financial targets, though it acknowledged a potential 50-basis-point hit to profitability margins.Following the announcement, JPMorgan lowered its price target on Ferrari to $460 from $525 while maintaining an 'Overweight' rating.President Donald Trump's decision to impose a steep 25% tariff on all vehicles imported into the U.S. has rattled the auto industry, dragging down shares of major automakers such as Ford and General Motors, as well as Germany's Volkswagen and Japan's Toyota.On Stocktwits, retail investor sentiment climbed into the 'neutral' zone from 'bearish' a day ago amid a 350% jump in message volume.<figure class="image"><img style="aspect-ratio:1318/302;" src="https://news.stocktwits-cdn.com/RACE_sentiment_and_message_volume_as_of_March_27_png_cc24c4ea78.webp" alt="RACE sentiment and message volume as of March 27.png" width="1318" height="302"><figcaption>RACE sentiment and message volume as of March 27. | source: Stocktwits</figcaption></figure>"This is and was one of my favorite car stocks... If you want to beat the Tariff route. Most people that can afford a RACE they can afford any price hike," said one user.<stembedurl>https://stocktwits.com/afernandez321/message/609452309</stembedurl>"Ferrari is not your typical carmaker: Its wealthy customers are willing to pay prices that can go as high as half a million dollars. Now, thanks to President Donald Trump's newly announced tariffs, they'll be paying even more," said another.<stembedurl>https://stocktwits.com/topstockalerts/message/609447993</stembedurl>Ferrari's stock surged last month after the automaker&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ferrari-stock-surges-on-big-q4-beat/chPraSjRrT">reported</a> stronger-than-expected fourth-quarter earnings, driven by a favorable product mix and rising demand for customizations.Analysts believe Ferrari's ability to keep demand above supply — coupled with the launch of ultra-expensive supercars — will continue to fuel earnings growth.Shares of Ferrari are up 1.4% this year. According to Koyfin data, 13 analysts cover the stock on Wall Street: five rate it 'buy' or 'strong buy'; six recommend 'hold,' while two rate it 'sell' or 'strong sell.'For updates and corrections, email newsroom[at]stocktwits[dot]com.

A vistitor views a 2024 Ferrari Roma Spider during the British Motor Show 2024 at Farnborough International Exhibition Centre on August 15, 2024 in Farnborough, England. (Photo by John Keeble/Getty Images)

Ferrari Adjusts Pricing To Counter Trump Tariffs: Retail Sentiment Climbs Despite After-Hours Dip

JPMorgan has lowered its price target on Ferrari to $460 from $525 while maintaining an 'Overweight' rating.

EFA
iShares MSCI EAFE ETF

Feed

News

Sentiment

Fundamentals

Info

Latest EFA News

EFAiShares MSCI EAFE ETF